Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review.

Nagem Lopes, Luis Phillipe; da Cunha, Lidiane Gomes; Silva, Alice Ramos Oliveira; Land, Marcelo Gerardin Poirot; Fonseca, Adriana Rodrigues; Lopes, Luciane Cruz; Lima, Elisangela Costa

Nagem Lopes, Luis Phillipe; da Cunha, Lidiane Gomes; Silva, Alice Ramos Oliveira; Land, Marcelo Gerardin Poirot; Fonseca, Adriana Rodrigues; Lopes, Luciane Cruz; Lima, Elisangela Costa.

Afiliação

Nagem Lopes LP; Post-Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil.
da Cunha LG; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Silva ARO; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Land MGP; Post-Graduate Program in Saúde Materno Infantil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Fonseca AR; Post-Graduate Program in Saúde Materno Infantil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Lopes LC; Post-Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil.
Lima EC; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Front Pharmacol ; 14: 1228986, 2023.

Article em En | MEDLINE | ID: mdl-37680713

Palavras-chave

COVID-19; high-cost medicines; multisystem inflammatory syndrome in children; pediatrics; social determinants of health

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google